Health

StoneWise AI-driven Drug Discovery Platform: Investigation and Repurpose of Nucleoside-based RNA Polymerase Inhibitors and Their Potential Use in COVID-19 Infection Treatment

BEIJING, Feb. 20, 2020 /PRNewswire/ -- In a campaign to screen drugs for the treatment of COVID-19, the disease caused by SARS-CoV-2, StoneWise, a company specialized in applying artificial intelligence to innovative drug design solutions for innovative drug R&D enterprises and institutions, has ...

2020-02-20 20:04 1302

Hyatt Regency Danang Resort and Spa Implemented Precautionary COVID-19 Measures

DA NANG, Vitenam, Feb. 20, 2020 /PRNewswire/ -- The safety and wellbeing of the guests and colleagues is a top priority. Hyatt hotels globally, including Hyatt Regency Danang Resort and Spa, have already implemented precautious measures in response to coronavirus concerns, including colleague edu...

2020-02-20 19:15 3856

Sihuan Pharmaceutical Announces Acquisition of All Interests and Intellectual Property Rights of Plazomicin, A New Generation of Aminoglycoside Antibiotics in the Greater China Region

HONG KONG, Feb. 20, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that Xuanzhu (HK) Biopharmaceutical Limited (''Xuanzhu''), a wholly-owned subsidiary of the...

2020-02-20 18:59 12803

111 to Announce Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results on March 12, 2020

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform inChina , today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2019 endedDecember 31, 2019, bef...

2020-02-20 17:15 10191

111 Partners with Financial Institutions in Battle Against Coronavirus

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI, "111" or the "Company") has announced that it will leverage its knowhow and technology in the battle against the novel coronavirus (COVID-19) public health crisis, through partnerships with some ofChina's leading financial institution...

2020-02-20 17:00 5176

Ten billion investment to build Chengdu medical city to create a new highland for the international health industry

CHENGDU, China, Feb. 20, 2020 /PRNewswire/ -- In 2019, with the continuous advancement of "three medical integration", Chengdu Medical City's three medical innovation center, as "Western China Biomedical Innovation Center", submitted a satisfactory answer sheet: 58 new contracted projects (47 thr...

2020-02-20 16:04 660

Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial

HOUSTON, Feb. 20, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficult-to-treat conditions, today announced it has signed an agreement with Mycenax Biotech for the production of material...

2020-02-20 15:15 1517

Industrial enterprises in Weifang, Shandong resume work and production while fighting epidemic

WEIFANG, China, Feb. 20, 2020 /PRNewswire/ -- In order to respond to the epidemic of novel coronavirus pneumonia (NCP), the government ofShandong Province has issued a notice that requires enterprises that are key to national economy and people's livelihoods to immediately resume work and product...

2020-02-20 13:37 1151

Infinitus releases 2019 Corporate Social Responsibility Report promoting a healthy lifestyle

GUANGZHOU, China, Feb.20, 2020 /PRNewswire/ -- The general public has come to see the taking of social responsibility as a basic requirement of all companies. On February 20, Infinitus (China) Company Ltd released its 2019 Corporate Social Responsibility Report on its online platform. Given th...

2020-02-20 10:00 2072

InDex Pharmaceuticals' In-depth Analysis of the CONDUCT Study Confirms the Successful Top Line Results and Supports the Strategy Going Forward

STOCKHOLM, Feb. 20, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the conclusions from in-depth analysis of the complete data set from the phase IIb dose optimisation study CONDUCT, evaluating the first-in-class TLR9 agonist cobitolimod for the treatment of moderate...

2020-02-20 06:00 1555

Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics

MADISON, Wisconsin, Feb. 20, 2020 /PRNewswire/ -- Nimble Therapeutics, Inc. today announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery and development of novel peptide-based medicines for targets across a range of diseases. The collaboration w...

2020-02-20 01:00 1889

Telangana State and MedTechConnect launch Project Tej

HYDERABAD, India, Feb. 19, 2020 /PRNewswire/ -- In order to provide a platform which can enable aspiring entrepreneurs to test their innovative ideas in the field of medical technologies, TheGovernment of Telangana and MedTechConnect, a platform founded by Cyient and Xynteo's India2022 coalition ...

2020-02-19 20:01 1744

TAT's travel recommendations regarding Thailand's Coronavirus Disease 2019 control measures

BANGKOK, Feb. 19, 2020 /PRNewswire/ -- On Thursday, 30 January, 2020, the World Health Organisation (WHO) declared the outbreak of the Coronavirus Disease (COVID-19) as a Public Health Emergency of International Concern (PHEIC). The WHO did not recommend any travel or trade restrictions based on ...

2020-02-19 19:48 1457

Conduent Market-Leading Disease Surveillance and Outbreak Management System to Fight Coronavirus

FLORHAM PARK, N.J., Feb. 19, 2020 /PRNewswire/ -- Conduent Incorporated  (Nasdaq: CNDT) today announced a version of its disease surveillance and outbreak management platform, Maven®, to securely track, manage and report on cases of the coronavirus, COVID-19, previously...

2020-02-19 18:04 6571

Announcement of Memorandum of Understanding for Launching Strategic joint venture of 5G network service business

TOKYO, Feb. 19, 2020 /PRNewswire/ -- BitOne Group Company Limited (hereinafter "The Company") and IBO Telecom Company Limited (hereinafter "IBO Telecom"), a Hong Kong-based subsidiary of IBO Technology Company Limited ("IBO Technology") are pleased to announce that we have signed a memorandum of ...

2020-02-19 17:00 2226

NeuroVive Pharmaceutical AB Year End Report January - December 2019

STOCKHOLM, Feb. 19, 2020 /PRNewswire/ -- Important events in 2019 KL1333            * NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study            * NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study            * NeuroVive compl...

2020-02-19 16:08 6072

Da Nang City is in the effort of prevention, fighting against the Out-break of COVID-19

DA NANG, Vietnam, Feb. 19, 2020 /PRNewswire/ -- Da Nang City has so far conducted efficient control over the situation while preventive measures against the epidemic have been applied at all destinations.Da Nang City is currently a safe destination. According to updates from the portal ofDa Nang...

2020-02-19 11:52 2463

UBM BN Co., Ltd., Announces SECON 2020 Show Postponement

SEOUL, South Korea, Feb. 19, 2020 /PRNewswire/ -- UBM BN Co., Ltd., the fair manager of SECON 2020 originally scheduled for 18 -20 March 2020 has made the decision to reschedule the event to6 - 8 July at KINTEX, Korea.   The decision is taken after careful consideration and close consultations ...

2020-02-19 10:00 1794

ASIAWATER 2020 Rescheduled to 30 November - 2 December 2020 in Kuala Lumpur, Malaysia

KUALA LUMPUR, Malaysia, Feb. 19, 2020 /PRNewswire/ -- ASIAWATER 2020 originally scheduled fromMarch 31- April 1, 2020 has now moved to the revised dates of 30 November –2 December, 2020 at the Kuala Lumpur Convention Center (KLCC).  According to Informa Markets, the Organizer of ASIAWATER 2020, t...

2020-02-19 09:00 2353

Amorepacific Group opens Green Tea Probiotics Research Center

SEOUL, South Korea, Feb. 19, 2020 /PRNewswire/ -- Amorepacific R&D Center opened Green Tea Probiotics Research Center to deepen the study of lactobacillus newly found in Jeju organic green tea garden and to continue the development of innovative products in microorganisms and other fields. 

2020-02-19 08:30 3024
1 ... 743744745746747748749 ... 822